![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
20
Finortex, S.l. Sant Llorenç D’hortons Es, based in Spain, is a pharmaceutical company.
One of their significant offerings is Ebastine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-139 - Rev 00
This Chemical Type CEP, issued on September 28, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2015 associated with this CEP further emphasizes